The historical rank and industry rank for Omega Healthcare Investors's 5-Year Yield-on-Cost % or its related term are showing as below:
During the past 13 years, Omega Healthcare Investors's highest Yield on Cost was 11.81. The lowest was 5.55. And the median was 7.63.
BSP:O2HI34's 5-Year Yield-on-Cost % is not ranked *
in the REITs industry.
Industry Median: 7.295 * Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Omega Healthcare Investors 5-Year Yield-on-Cost % Related Terms
BSP:O2HI34 vs DOC, AHR, CTRE: 5-Year Yield-on-Cost % Comparison
For the REIT - Healthcare Facilities subindustry, Omega Healthcare Investors's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Omega Healthcare Investors 5-Year Yield-on-Cost % vs REITs Industry
For the REITs industry and Real Estate sector, Omega Healthcare Investors's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Omega Healthcare Investors's 5-Year Yield-on-Cost % falls into.
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Omega Healthcare Investors (BSP:O2HI34) has a 5-Year Yield-on-Cost % of 0.00 as of Jun. 25, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Omega Healthcare Investors and its competitors. Over the past decade, Omega Healthcare Investors' 5-Year Yield-on-Cost % has ranged from 5.55 to 11.81. According to the industry distribution chart, Omega Healthcare Investors ranks #581 out of 876 companies in the REITs industry, placing it in the top 66.3%.
Is Omega Healthcare Investors' 5-Year Yield-on-Cost % too high?
Omega Healthcare Investors' current 5-Year Yield-on-Cost % is 0.00. Over the past 10 years, this metric has ranged from a low of 5.55 to a high of 11.81. Based on the distribution chart, Omega Healthcare Investors ranks #581 out of 876 companies in the REITs industry, which is below the industry midpoint. Overall, Omega Healthcare Investors has a GF Score™ of 49/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Omega Healthcare Investors' 5-Year Yield-on-Cost % compare to DOC and AHR?
According to the REITs industry distribution chart, Omega Healthcare Investors ranks #581 out of 876 companies for 5-Year Yield-on-Cost %. This places Omega Healthcare Investors in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 7.30. Historically, Omega Healthcare Investors' own 5-Year Yield-on-Cost % has ranged from 5.55 to 11.81 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a REITs company?
The median 5-Year Yield-on-Cost % among REITs companies is 7.30, based on 876 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Omega Healthcare Investors and its competitors. For the REITs industry, the median 5-Year Yield-on-Cost % is 7.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Omega Healthcare Investors's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Omega Healthcare Investors stock overvalued right now?
Based on GuruFocus' analysis, Omega Healthcare Investors (BSP:O2HI34) is currently considered Modestly Overvalued. The stock's GF Value™ is R$60.64, compared to a current price of R$77.02 — trading 27% above its estimated fair value. The current 5-Year Yield-on-Cost % is 0.00. Omega Healthcare Investors' overall GF Score™ is 49/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Omega Healthcare Investors (BSP:O2HI34), the current 5-Year Yield-on-Cost % is 0.00 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Omega Healthcare Investors (BSP:O2HI34) Overvalued in 2026?
Based on GuruFocus' analysis, Omega Healthcare Investors stock appears to be overvalued.
The current stock price of R$77.02 is trading 27% above its estimated GF Value™ of R$60.64.
GuruFocus considers Omega Healthcare Investors to be Modestly Overvalued.
Key valuation signals for BSP:O2HI34:
5-Year Yield-on-Cost %: 0.00
GF Value™: R$60.64 vs. price of R$77.02 (27% above fair value)
No single metric tells the full story. See the BSP:O2HI34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Omega Healthcare Investors Inc is a real estate investment trust that invests in healthcare-related real estate properties located in the United States (U.S.), the United Kingdom (U.K.), and Canada. The company's objective is to provide attractive returns to investors while serving as the preferred capital partner to its third-party healthcare operating companies and affiliates, as well as other third-party healthcare operators, allowing them to focus on delivering a high level of care to their resident patients. Omega's investment portfolio mainly consists of skilled nursing facilities, assisted living facilities (ALFs), including care homes in the U.K., independent living facilities, rehabilitation and acute care facilities, and continuing care retirement communities.
49GF Score
Get the complete analysis for BSP:O2HI34
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSP:O2HI34 has been successfully added to your 